The analysis presented is extracted from the actual experience of NHFcard Beneficiaries at NHF Provider pharmacies which is officially obtained from the National Health Fund.

Demographic data reflects the profile of the NHFcard Beneficiary database of 200,000 persons – 7% of the total population.  Sales data represents the experience of Beneficiary purchases with actual quantities purchased and prices paid.  With 1.8 million claims paid for a patient cost of $2.8 billion (US$40 million), the NHFcard represents approximately 55% of the total prescription drug market in Jamaica and an even greater share of the market for those drugs covered.  Over 85% of NHFcard benefits are accessed at commercial pharmacies and the data presented reflects this sales activity.  Information on consumption in the public sector can be provided separately.

Three report sets are offered

Active Pharmaceutical Ingredient (API) Reports provide a detailed analysis of the market for each molecule.  Analyses are presented for each presentation of the drug by quantity and retail value with geographic and demographic distributions.

Therapeutic Reports provide a detailed analysis of the market for a specified set of drugs as determined by the Client.  Analyses are presented for each drug by quantity and retail value with geographic and demographic distributions.

Market Reports provide a detailed analysis of the chronic disease market for each illness.  Analyses are presented for each illness by quantity and retail value with geographic and demographic distributions.
see presentation for a review of the analysis and reports provided

For more information please email radobar@cwjamaica.com


Slide 12
LEARN HOW TO GET THAT COMPETITIVE ADVANTAGE FOR YOUR PHARMACEUTICAL PRODUCTS IN DEVELOPING COUNTRY MARKETS

Market share analysis
Is the market for your product growing?
Is your product maintaining market share?
In which geographic areas are you being outperformed?

Competitive analysis
How are competitive API performing?
Are they growing faster than your API?

Therapeutic Market analysis
Is the market for this Therapeutic category growing?
Is your API maintaining market share?
How are competitive API performing?
In which geographic areas are you being outperformed?

Slide 14
Chronic Disease Market analysis
What are Jamaican patients spending their prescription dollar on?
What is the market size for a CNCD?  Where is it – parish?  Who is it – age?

Market Watch
You have a product not listed with the NHFcard but is used in conjunction with a condition and medications covered by the NHFcard
What is the market for the NHFcard medication with which my product is used
Is my product performing as well as the NHFcard medication?
Where - parish?
Slide 15